BiotechTube
Home/Sanuwave/Morgan Frank
MF

Morgan Frank

Chief Executive Officer & Chairman of the Board

Sanuwave

Therapeutic Areas

Advanced Wound CareRegenerative Medicine

Sanuwave Pipeline

DrugIndicationPhase
UltraMIST® Therapy SystemChronic, Non-Healing Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers)Commercial

Leadership Team at Sanuwave

PS
Peter Sorensen
Chief Financial Officer
DL
Dustin Libby
Executive Vice President of Commercial Operations
TW
Tim Wern
Executive Vice President of Sales – U.S. Wound
JT
Jim Tyler
Director
IM
Ian Miller
Director
JB
Jeffrey Blizard
Director
GB
Greg Bazar
Director
View full Sanuwave profile